Antonio Marra, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn:
“As ESMO 2025 comes to a close, the momentum in oncology has never felt stronger. Nearly 37,000 attendees from across the globe came together to share practice-changing data and chart what’s next for cancer care.
It was a privilege to serve as a discussant in the Developmental Therapeutics session, where we saw compelling data on novel agents agents and rational combinations — work that is opening the door to more precise, less toxic treatment options for our patients.
Grateful for the science, the collaboration, and the shared commitment to change outcomes.
A huge congratulations and thanks to Myriam Chalabi and Toni Choueiri for a stellar scientific program!
Already looking ahead to ESMO 2026 in Madrid.”
More posts from ESMO25.
